Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Galmarini

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Medical Oncology (Northwood, London, England)|January 16, 2015
Survivorship in untreated breast cancer patientsCarlos M Galmarini, Olivier Tredan, Felipe C Galmarini
British Journal of Haematology|November 28, 2008
CP-4055 and CP-4126 are active in ara-C and gemcitabine-resistant lymphoma cell linesCarlos M Galmarini, Finn Myhren, Marit L Sandvold
American Journal of Reproductive Immunology : AJRI : Official Journal of the American Society for the Immunology of Reproduction and the International Coordination Committee for Immunology of Reproduction|September 1, 1983
Specific suppression of humoral and delayed hypersensitivity responses by cyclophosphamide in an experimental model of autoimmunityC M Riera, M Galmarini, H M Serra
The Lancet. Oncology|July 27, 2002
Nucleoside analogues and nucleobases in cancer treatmentCarlos M Galmarini, John R Mackey, Charles Dumontet
Cancer Chemotherapy and Pharmacology|February 8, 2006
Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cellsLars Petter Jordheim, Carlos M Galmarini, Charles Dumontet
Critical Reviews in Oncology/Hematology|May 1, 2012
Cancer chemotherapy: a critical analysis of its 60 years of historyDarío Galmarini, Carlos M Galmarini, Felipe C Galmarini
Journal of Reproductive Immunology|July 1, 1988
Delayed hypersensitivity and lesions following isoimmunization with modified rat male accessory glands: kinetics of inductionM Galmarini, M E Ferro, C M Riera
Cancer Metastasis Reviews|December 19, 2013
Concomitant resistance and early-breast cancer: should we change treatment strategies?Carlos M Galmarini, Olivier Tredan, Felipe C Galmarini
Cancer Chemotherapy and Pharmacology|December 16, 2015
Unique features of trabectedin mechanism of actionAnnette K Larsen, Carlos M Galmarini, Maurizio D'Incalci
Medicina|January 1, 1988
[Factors involved in enhancing autoimmune response in aging animals]M C Pistoresi-Palencia, M Galmarini, E Vottero-Cima
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Medical Oncology (Northwood, London, England)|January 16, 2015
Survivorship in untreated breast cancer patientsCarlos M Galmarini, Olivier Tredan, Felipe C Galmarini
British Journal of Haematology|November 28, 2008
CP-4055 and CP-4126 are active in ara-C and gemcitabine-resistant lymphoma cell linesCarlos M Galmarini, Finn Myhren, Marit L Sandvold
American Journal of Reproductive Immunology : AJRI : Official Journal of the American Society for the Immunology of Reproduction and the International Coordination Committee for Immunology of Reproduction|September 1, 1983
Specific suppression of humoral and delayed hypersensitivity responses by cyclophosphamide in an experimental model of autoimmunityC M Riera, M Galmarini, H M Serra
The Lancet. Oncology|July 27, 2002
Nucleoside analogues and nucleobases in cancer treatmentCarlos M Galmarini, John R Mackey, Charles Dumontet
Cancer Chemotherapy and Pharmacology|February 8, 2006
Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cellsLars Petter Jordheim, Carlos M Galmarini, Charles Dumontet
Critical Reviews in Oncology/Hematology|May 1, 2012
Cancer chemotherapy: a critical analysis of its 60 years of historyDarío Galmarini, Carlos M Galmarini, Felipe C Galmarini
Journal of Reproductive Immunology|July 1, 1988
Delayed hypersensitivity and lesions following isoimmunization with modified rat male accessory glands: kinetics of inductionM Galmarini, M E Ferro, C M Riera
Cancer Metastasis Reviews|December 19, 2013
Concomitant resistance and early-breast cancer: should we change treatment strategies?Carlos M Galmarini, Olivier Tredan, Felipe C Galmarini
Cancer Chemotherapy and Pharmacology|December 16, 2015
Unique features of trabectedin mechanism of actionAnnette K Larsen, Carlos M Galmarini, Maurizio D'Incalci
Medicina|January 1, 1988
[Factors involved in enhancing autoimmune response in aging animals]M C Pistoresi-Palencia, M Galmarini, E Vottero-Cima
Pageof 13